Makers Laboratories Ltd.

136.05 -4.90 ▼-3.5%

22 February 2024, 04:01:00 PM
Volume: 15,606

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.makerslabs.com
Market Cap 80.27 Cr.
Enterprise Value(EV) 91.07 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -8.91 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.89 Trailing Twelve Months Ending 2023-12
Book Value / Share 109.63 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.24 Calculated using Price: 136.05
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.59 Cr. 5,900,376 Shares
FaceValue 10
About Makers Laboratories Ltd.
Makers Laboratories was incorporated in 1985. The company is promoted and managed by Ipca Laboratories group. The company is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The company's plants are located in Palghar and Dombivli in Thane (Maharashtra). The company has a prominent presence in the therapeutic segment of antibiotics.

Makers Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Makers Laboratories Ltd. Performance

1 Day
-3.48%
1 Week
+6.29%
1 Month
+0.04%
3 Month
+23.68%
6 Month
+20.13%
1 Year
+35.91%
2 Year
-23.91%
5 Year
+179.42%
10 Year
+743.98%

Makers Laboratories Ltd. Fundamental Ratios

3 years 2021-03 2022-03 2023-03
Return on Equity (%) 2.49 20.61 -3.4
Return on Capital Employed (%) 6.53 24 1.72
Return on Assets (%) 0.99 8.35 -1.48

Makers Laboratories Ltd. Balance Sheet

Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 54 60 69 66
Non Curr. Liab. 17 13 15 17
Curr. Liab. 33 33 28 30
Minority Int. 32 39 40 40
Equity & Liab. 136 144 152 154
Non Curr. Assets 75 81 89 89
Curr. Assets 61 63 63 64
Misc. Exp. not W/O
Total Assets 136 144 152 154

Makers Laboratories Ltd. Profit and Loss

Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 69 127 101 106
Other Income 1 3 2 1
Total Income 70 130 104 107
Total Expenditure -61 -108 -98 -104
PBIDT 9 21 6 3
Interest -2 -2 -2 -2
Depreciation -5 -4 -4 -5
Taxation -1 -4 -1 0
Exceptional Items 0
PAT 1 12 -2 -4
Minority Interest -2 -7 -3 -2
Share Associate
Other Related Items
Consolidated Net Profit 0 5 -5 -5
Adjusted EPS -1 10 -8 -9

Makers Laboratories Ltd. Cash Flow

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 19 -9
Cash Fr. Inv. -22 1
Cash Fr. Finan. 0 6
Net Change -3 -2
Cash & Cash Eqvt 2 1

Makers Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 58.37 58.37 61.27 61.27 61.27 61.27 61.27 61.27 61.27
Public 41.63 41.63 38.73 38.73 38.73 38.73 38.73 38.73 38.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Makers Laboratories Ltd. Announcements

Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of the Consolidated Unaudited Financial Results for the 3rd quarter & 9 months ended 31st December 2023
Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary /Compliance Officer / Key Managerial Personnel
Tue, 13 Feb 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.02.2024
Outcome of the Board Meeting held on 13.02.2024

Makers Laboratories Ltd. Technical Scans

Thu, 22 Feb 2024
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 3 Months High Increase in 3 Months

Makers Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,756.40 1,553.75 +0.7%
Cipla Ltd. 117,370.75 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. 106,155.83 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. 97,309.86 6,766.05 +0.1%
Divi's Laboratories Ltd. 96,809.75 3,642.80 -0.2%
Zydus Lifesciences Ltd. 91,584.23 904.80 +1.3%
Torrent Pharmaceuticals Ltd. 88,295.34 2,611.70 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.97 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 31.65 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.28 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 70.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.80 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,611.70 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 4.53 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.95 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.71 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,611.70 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,611.70 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,611.70 +0.4%

Makers Laboratories Ltd. FAQ's

What is Makers Laboratories share price?

Can I buy Makers Laboratories shares now?

What is the Market Cap of Makers Laboratories?

What are the key metrics to analyse Makers Laboratories?

What is the 52 Week High and Low of Makers Laboratories?

What is the trend of Makers Laboratories share price?